Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer
The study is the single arm and single center clinical trials，We conduct the phase II clinical trial to further explore the efficacy and safety of Apatinib and chemotherapy sequential treatment with advanced recurrence of metastatic cervical cancer
Cervical Cancer
DRUG: Apatinib
Progression free survival, 24 months
overall survival, 24 months
The study is the single arm and single center clinical trials，We conduct the phase II clinical trial to further explore the efficacy and safety of Apatinib and chemotherapy sequential treatment with advanced recurrence of metastatic cervical cancer